2002
DOI: 10.1074/jbc.m109185200
|View full text |Cite
|
Sign up to set email alerts
|

Dimeric Versions of Two Short N-cadherin Binding Motifs (HAVDI and INPISG) Function as N-cadherin Agonists

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
56
1

Year Published

2003
2003
2018
2018

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 55 publications
(57 citation statements)
references
References 46 publications
0
56
1
Order By: Relevance
“…Studies have shown that the identity of the amino acids that flank the HAV motif determines both the activity and specificity of the mimetic peptides (26). Furthermore, the cyclic form of cadherin mimetic peptides exhibits significantly higher activity than linear peptides (40). Therefore, further optimization of the peptide sequence and structure could produce an even more robust chondrogenic effect than that observed here.…”
Section: Discussioncontrasting
confidence: 44%
See 1 more Smart Citation
“…Studies have shown that the identity of the amino acids that flank the HAV motif determines both the activity and specificity of the mimetic peptides (26). Furthermore, the cyclic form of cadherin mimetic peptides exhibits significantly higher activity than linear peptides (40). Therefore, further optimization of the peptide sequence and structure could produce an even more robust chondrogenic effect than that observed here.…”
Section: Discussioncontrasting
confidence: 44%
“…Monomeric versions of this motif generally function as antagonists by competing against natural binding sites in the N-cadherin ECD1 domain, whereas dimeric versions are capable of acting as agonists by promoting dimerization of N-cadherins in cells (40). In this study, because one end (C-terminal) of the peptide was conjugated to the HA hydrogel backbone, a monomeric linear peptide sequence containing the HAV motif was capable of mimicking N-cadherin agonistic activity.…”
Section: Discussionmentioning
confidence: 99%
“…It would have been more informative if the E-cadherin-derived cyclic peptides were shown to inhibit E-cadherin, but not N-cadherin adhesion. Further evidence for the involvement of EC1 in cadherin adhesion was revealed in a study from the same group on small peptide agonists of cadherin adhesion (Williams et al 2002). The authors demonstrated that a recombinant N-cadherin EC1 domain was able to inhibit neurite outgrowth from cerebellar neurons over 3T3 cells expressing N-cadherin.…”
Section: Early Studiesmentioning
confidence: 93%
“…Cis-dimerization has also been examined using peptides (Williams et al 2002). Short peptide HAV-containing antagonists were dimerized so that two adhesion sites were on the same molecule.…”
Section: Cadherin Adhesion Structure: Cis-dimermentioning
confidence: 99%
“…Several experiments have been published with substratum bound N-cadherin peptides containing HAV-sequence dimeric versions of the N-CAD peptides promote neuronal cell survival and neurite outgrowth, while cyclic peptides containing the HAV-sequence of extracellular domain 1 induce FGF-receptor-mediated apoptosis in endothelial cells [36] and inhibit neurite outgrowth [37]. When presented as soluble molecules, dimeric peptides stimulate neurite outgrowth in a manner similar to native N-cadherin [38,39].…”
Section: Discussionmentioning
confidence: 99%